BIOMAT Database Logo BIOMAT Database Logo

Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. 2000

A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. tahara@yamanouchi.co.jp

[(3)H]-oxytocin was used to characterize the oxytocin receptor found in human uterine smooth muscle cells (USMC). Specific binding of [(3)H]-oxytocin to USMC plasma membranes was dependent upon time, temperature and membrane protein concentration. Scatchard plot analysis of equilibrium binding data revealed the existence of a single class of high-affinity binding sites with an apparent equilibrium dissociation constant (K(d)) of 0.76 nM and a maximum receptor density (B(max)) of 153 fmol mg(-1) protein. The Hill coefficient (n(H)) did not differ significantly from unity, suggesting binding to homogenous, non-interacting receptor populations. Competitive inhibition of [(3)H]-oxytocin binding showed that oxytocin and vasopressin (AVP) receptor agonists and antagonists displaced [(3)H]-oxytocin in a concentration-dependent manner. The order of potencies for peptide agonists and antagonists was: oxytocin>[Asu(1,6)]-oxytocin>AVP= atosiban>d(CH(2))(5)Tyr(Me)AVP>[Thr(4),Gly(7)]-oxytocin>dDAVP, and for nonpeptide antagonists was: L-371257>YM087>SR 49059>OPC-21268>SR 121463A>OPC-31260. Oxytocin significantly induced concentration-dependent increase in intracellular Ca(2+) concentration ([Ca(2+)](i)) and hyperplasia in USMC. The oxytocin receptor antagonists, atosiban and L-371257, potently and concentration-dependently inhibited oxytocin-induced [Ca(2+)](i) increase and hyperplasia. In contrast, the V(1A) receptor selective antagonist, SR 49059, and the V(2) receptor selective antagonist, SR 121463A, did not potently inhibit oxytocin-induced [Ca(2+)](i) increase and hyperplasia. The potency order of antagonists in inhibiting oxytocin-induced [Ca(2+)](i) increase and hyperplasia was similar to that observed in radioligand binding assays. In conclusion, these data provide evidence that the high-affinity [(3)H]-oxytocin binding site found in human USMC is a functional oxytocin receptor coupled to [Ca(2+)](i) increase and cell growth. Thus human USMC may prove to be a valuable tool in further investigation of the physiologic and pathophysiologic roles of oxytocin in the uterus. British Journal of Pharmacology (2000) 129, 131 - 139

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
The effect of relaxin on the oxytocin receptor in human uterine smooth muscle cells.
February 2007, Regulatory peptides,
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Interleukin-6 up-regulates the oxytocin receptor in cultured uterine smooth muscle cells.
March 2001, American journal of reproductive immunology (New York, N.Y. : 1989),
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
The characterization of human uterine smooth muscle cells in culture.
February 1979, Cell and tissue research,
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Interleukin-1 beta down-regulates the oxytocin receptor in cultured uterine smooth muscle cells.
February 2000, American journal of reproductive immunology (New York, N.Y. : 1989),
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Characterization of sodium channels in cultured human uterine smooth muscle cells.
January 1991, American journal of obstetrics and gynecology,
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Production of oxytocin receptor and cytokines in primary uterine smooth muscle cells cultivated under inflammatory conditions.
January 2002, Journal of the Society for Gynecologic Investigation,
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Effect of IL-1beta and IL-6 on oxytocin secretion in human uterine smooth muscle cells.
September 2001, American journal of reproductive immunology (New York, N.Y. : 1989),
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Pharmacologic characterization of human male urethral smooth muscle: an in vitro approach.
December 2013, Urology,
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Effect of oxytocin on calcium movements in uterine smooth muscle.
January 1985, Regulatory peptides. Supplement,
A Tahara, and J Tsukada, and Y Tomura, and K i Wada, and T Kusayama, and N Ishii, and T Yatsu, and W Uchida, and A Tanaka
Characterization of an oxytocin-induced rise in [Ca2+]i in single human myometrium smooth muscle cells.
July 1996, Cell calcium,
Copied contents to your clipboard!